Related Experiment Video
Updated: Dec 18, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Interatrial block and its association with an increased risk of ischemic stroke: A systematic review and
Narut Prasitlumkum1, Wisit Cheungpasitporn2, Raktham Mekritthikrai1
1Department of Medicine, University of Hawaii, Honolulu, HI, USA.
Insights
Advanced interatrial block (IAB) significantly increases stroke risk, while partial IAB does not. History of stroke modifies this risk, highlighting the need for further research in stroke risk stratification.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Interatrial block (IAB) has been suggested to associate with ischemic stroke risk.
- No comprehensive systematic review and meta-analysis has previously assessed this relationship.
Purpose of the Study:
- To conduct a systematic review and meta-analysis to evaluate the association between interatrial block (IAB) and ischemic stroke.
- To determine if different types of IAB (partial vs. advanced) pose varying risks for stroke.
Main Methods:
- A systematic search of MEDLINE, EMBASE, PUBMED, and Cochrane databases was performed up to January 2020.
- Included were observational studies comparing ischemic stroke risk in patients with and without IAB.
- Data were pooled using random-effects models to calculate risk ratios and 95% confidence intervals (CIs).
Main Results:
- Ten studies with 177,249 participants were analyzed.
- Advanced IAB was associated with an increased risk of stroke (OR 1.85, 95% CI 1.37-2.50, p < 0.001).
- Partial IAB showed no significant association with increased stroke risk (OR 1.19, 95% CI 0.99-1.43, p = 0.054).
- Subgroup analysis indicated a higher risk of recurrent stroke in patients with prior stroke, particularly those with advanced IAB (OR 4.73).
Conclusions:
- Only advanced interatrial block is significantly associated with an increased risk of stroke.
- A history of stroke may modify the relationship between IAB and recurrent stroke risk.
- Further research is needed to confirm these findings for clinical stroke risk stratification.
Introduction:
Several studies have suggested the association between interatrial block (IAB) and ischemic stroke. As no prior collective study has been discerned in this issue, we hence conducted systemic review and meta-analysis to assess the relationship between IAB and ischemic stroke.
Methods:
We comprehensively searched the databases of MEDLINE, EMBASE, PUBMED, and the Cochrane from inception to January 2020. Included studies were published observational studies that compared the risk of ischemic stroke among patients with and without IAB. Data from each study were combined using the random-effects, generic inverse variance method of DerSimonian and Laird to calculate risk ratios and 95% confidence intervals (CIs). Subgroup analyses and meta-regression were performed to explore heterogeneity.
Results:
Ten studies were included in this analysis, involving total 177,249 participants. Our study demonstrated no association between partial IAB and an increased risk of ischemic stroke with OR 1.19 (95% CI 0.99-1.43 p = 0.054),but a statistical correlation with an increased risk of stroke with OR 1.85 (95% CI 1.37-2.50, p < 0.001) in advanced IAB. Interestingly, our subgroup analysis of patients with prior stroke suggested higher risk of recurrent stroke in both advanced IAB (OR 4.73) and partial IAB (OR 1.65). Meta-regression suggested a history of stroke as an effect modifier in the interplay between IAB and risk of recurrent stroke.
Conclusion:
Only advanced IAB is associated with an increased risk of stroke. However, further studies are warranted to further support this finding to confirm its clinical feasibility in stroke risk stratification.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Coronary Artery Disease II: Pathophysiology

